A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Clinical trial NCT05776927 · RECRUITING
Trial details
- NCT number
- NCT05776927
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-04
- Primary completion
- 2028-12-30
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.